Rolling coverage of the latest economic and financial news. Good morning, and welcome to our rolling coverage of business, the financial markets and the world economy ... The region is reorganizing, preparing for the possibility of a prolonged conflict.
The combination of Roche’s investigational drug, giredestrant, with Pfizer’s Ibrance didn’t lead to a statistically significant improvement among patients with advanced breast cancer ... .
The company said the data supported further development of the drug in chronic weight management on its own or in combination with other drugs due to its tolerability ... .